426 related articles for article (PubMed ID: 19282767)
21. Cholangiocarcinoma arising from preexisting biliary hamartoma of liver--report of a case.
Orii T; Ohkohchi N; Sasaki K; Satomi S; Watanabe M; Moriya T
Hepatogastroenterology; 2003; 50(50):333-6. PubMed ID: 12749215
[TBL] [Abstract][Full Text] [Related]
22. Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma.
Hasebe T; Sakamoto M; Mukai K; Kawano N; Konishi M; Ryu M; Fukamachi S; Hirohashi S
Virchows Arch; 1995; 426(2):209-13. PubMed ID: 7757293
[TBL] [Abstract][Full Text] [Related]
23. [Cholangiocarcinoma arising from biliary micro-hamartomas in a man suffering from hemochromatosis].
Yaziji N; Martin L; Hillon P; Favre JP; Henninger JF; Piard F
Ann Pathol; 1997 Oct; 17(5):346-9. PubMed ID: 9471152
[TBL] [Abstract][Full Text] [Related]
24. Lymphoepithelioma-like cholangiocarcinoma not associated with EBV.
Adachi S; Morimoto O; Kobayashi T
Pathol Int; 2008 Jan; 58(1):69-74. PubMed ID: 18067645
[TBL] [Abstract][Full Text] [Related]
25. Intestinal type cholangiocarcinoma of intrahepatic large bile duct associated with hepatolithiasis--a new histologic subtype for further investigation.
Bae JY; Park YN; Nakanuma Y; Lee WJ; Kim JY; Park C
Hepatogastroenterology; 2002; 49(45):628-30. PubMed ID: 12063956
[TBL] [Abstract][Full Text] [Related]
26. Cholangiocarcinoma arising in von Meyenburg complexes.
Kim HK; Jin SY
Korean J Hepatol; 2011 Jun; 17(2):161-4. PubMed ID: 21757989
[No Abstract] [Full Text] [Related]
27. Intrahepatic cholangiocarcinoma metastatic to the ovary: a report of 16 cases of an underemphasized form of secondary tumor in the ovary that may mimic primary neoplasia.
Khunamornpong S; Siriaunkgul S; Suprasert P; Pojchamarnwiputh S; Na Chiangmai W; Young RH
Am J Surg Pathol; 2007 Dec; 31(12):1788-99. PubMed ID: 18043033
[TBL] [Abstract][Full Text] [Related]
28. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
29. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
30. [Diffuse bile duct papillomatosis: high rate of recurrence and risk of malignant transformation].
Brönnimann S; Zimmermann A; Baer HU
Chirurg; 1996 Jan; 67(1):93-7. PubMed ID: 8851683
[TBL] [Abstract][Full Text] [Related]
31. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
32. Malignant Transformation in Von-Meyenburg Complexes: Histologic and Immunohistochemical Clues With Illustrative Cases.
Parekh V; Peker D
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):607-14. PubMed ID: 25789533
[TBL] [Abstract][Full Text] [Related]
33. Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
Sano T; Yamamoto J; Kosuge T; Inoue K; Shimada K; Takayama T; Yamazaki S; Sakamoto M; Hirohashi S
Hepatogastroenterology; 1996; 43(9):667-70. PubMed ID: 8799413
[TBL] [Abstract][Full Text] [Related]
34. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.
Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E
Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296
[TBL] [Abstract][Full Text] [Related]
35. Synchronous carcinoma of the gallbladder in a patient with intrahepatic bile duct carcinoma.
Taniai N; Onda M; Tajiri T; Yoshida H; Naitou Z
Hepatogastroenterology; 2000; 47(31):121-4. PubMed ID: 10690592
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
38. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
[TBL] [Abstract][Full Text] [Related]
40. Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma.
Itatsu K; Fujii T; Sasaki M; Zen Y; Nakanuma Y
Hepatogastroenterology; 2007; 54(75):677-80. PubMed ID: 17591040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
